GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of botulinum neurotoxin BONT/A C134 mutant with mtsea modified cys-165 causing stretch disorder

Analyse Crystal structure of the catalytic domain of botulinum neurotoxin BONT/A C134… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4KUF
Type
protein
Length
426 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin a light chain
EC
3.4.24.69
UniProt
A5HZZ9
Ligands
LMR, NA, ZN
Pockets
6 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin a light chain (EC 3.4.24.69)protein42631% helix, 18% strandA5HZZ9

Ligands and binding sites

  • LMR · (2S)-2-hydroxybutanedioic acid · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A
  • ZN · Zinc ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 4 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14330.800.8849EDO
21350.520.8123empty
3880.390.7715EDO
4920.350.7416empty
5530.330.7814empty

Modifications

Observed in the structure: 1 modified (nonstandard).

Compared structures

  • 4KUF · Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134 mutant with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.